Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068133 · ClinicalTrials.gov registry record · Phase 2
Trial of VLTS-589 in Subjects With Intermittent Claudication
A Phase 2 study, sponsored by Valentis.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00068133: Completed Phase 2 study, sponsored by Valentis.
NCT00068133 is a Phase 2 study that has completed, run by Valentis. The registered enrollment target is 100 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00068133, a Phase 2 study, has completed, sponsored by Valentis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared with placebo, administered bilaterally to the lower extremities, in subjects with intermittent claudication and to determine the effect of VLTS-589 in peak walking time (PWT) for subjects receiving VLTS-589 compared with subjects receiving placebo.
Interventions
- GENETIC Plasmid based Gene Transfer product-VLTS-589
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
What the finished NCT00068133 record still lists
NCT00068133 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower).
The record links to 0 conditions, and to 1 intervention - of which Plasmid based Gene Transfer product-VLTS-589 is the first listed.
NCT00068133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00068133 about?
NCT00068133 is a clinical study titled "Trial of VLTS-589 in Subjects With Intermittent Claudication". The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared with placebo, administered bilaterally to the lower extremities, in subjects with intermittent claudication and to determine the effect of VLTS-589 in peak walking time (PWT) for subjects receiving VLTS-589 com...
What is the current status of trial NCT00068133?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2003-06. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00068133?
The interventions under investigation include: Plasmid based Gene Transfer product-VLTS-589 (GENETIC).
Who is sponsoring clinical trial NCT00068133?
This trial is sponsored by Valentis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00068133's enrollment target sits among peer trials
100 672nd of 2000 higher than 1,263 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia